Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
213.21
-5.77 (-2.63%)
May 15, 2026, 4:00 PM EDT - Market closed
Ligand Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$257.71
Upside
+20.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $252 → $262 | Buy | Maintains | $252 → $262 | +22.88% | May 8, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $243 → $289 | Strong Buy | Maintains | $243 → $289 | +35.55% | Apr 30, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $235 → $252 | Buy | Maintains | $235 → $252 | +18.19% | Apr 28, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $276 → $282 | Strong Buy | Maintains | $276 → $282 | +32.26% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $239 → $243 | Strong Buy | Maintains | $239 → $243 | +13.97% | Apr 14, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $270 → $276 | Strong Buy | Maintains | $270 → $276 | +29.45% | Mar 24, 2026 |
| B of A Securities | B of A Securities | Strong Buy Initiates $244 | Strong Buy | Initiates | $244 | +14.44% | Mar 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | +29.92% | Feb 27, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $231 → $239 | Strong Buy | Maintains | $231 → $239 | +12.10% | Feb 24, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $234 → $235 | Buy | Maintains | $234 → $235 | +10.22% | Dec 10, 2025 |
| Stifel | Stifel | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +7.87% | Dec 10, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +26.64% | Dec 9, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $185 → $234 | Buy | Maintains | $185 → $234 | +9.75% | Nov 10, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +28.98% | Nov 7, 2025 |
| Benchmark | Benchmark | Strong Buy Maintains $175 → $220 | Strong Buy | Maintains | $175 → $220 | +3.18% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $206 → $231 | Strong Buy | Maintains | $206 → $231 | +8.34% | Nov 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.